troglitazone has been researched along with Adhesions, Tissue in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, S | 1 |
| Furuyama, N | 1 |
| Yada, S | 1 |
| Hamaura, T | 1 |
| Kusai, A | 1 |
| Yonemochi, E | 1 |
| Terada, K | 1 |
1 other study available for troglitazone and Adhesions, Tissue
| Article | Year |
|---|---|
Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.
Topics: Calorimetry, Differential Scanning; Chromans; Chromatography, Gas; Crystallography; Excipients; Hot | 2007 |